QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 15, Issue 11, 5064-5074, November 2004

This Article Full Text Full Text (PDF) All Versions of this Article: E04-03-0184v1 15/11/5064    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ren, Y.-G. Articles by Deveraux, Q. L. Search for Related Content PubMed PubMed Citation Articles by Ren, Y.-G. Articles by Deveraux, Q. L.

Differential Regulation of the TRAIL Death Receptors DR4 and DR5 by the Signal Recognition Particle

Yan-Guo Ren ^*, Klaus W. Wagner ^* , Deborah A. Knee , Pedro Aza-Blanc , Marc Nasoff , and Quinn L. Deveraux ^* ||

^* Department of Cancer Biology, Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121; Department of Protein Sciences, Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121; and Department of Genomics, Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121

Submitted March 5, 2004; Revised August 17, 2004; Accepted August 27, 2004
Monitoring Editor: Keith Yamamoto

TRAIL (TNF-related apoptosis-inducing ligand) death receptors DR4 and DR5 facilitate the selective elimination of malignant cells through the induction of apoptosis. From previous studies the regulation of the DR4 and DR5 cell-death pathways appeared similar; nevertheless in this study we screened a library of small interfering RNA (siRNA) for genes, which when silenced, differentially affect DR4- vs. DR5-mediated apoptosis. These experiments revealed that expression of the signal recognition particle (SRP) complex is essential for apoptosis mediated by DR4, but not DR5. Selective diminution of SRP subunits by RNA interference resulted in a dramatic decrease in cell surface DR4 receptors that correlated with inhibition of DR4-dependent cell death. Conversely, SRP silencing had little influence on cell surface DR5 levels or DR5-mediated apoptosis. Although loss of SRP function in bacteria, yeast and protozoan parasites causes lethality or severe growth defects, we observed no overt phenotypes in the human cancer cells studied—even in stable cell lines with diminished expression of SRP components. The lack of severe phenotype after SRP depletion allowed us to delineate, for the first time, a mechanism for the differential regulation of the TRAIL death receptors DR4 and DR5—implicating the SRP complex as an essential component of the DR4 cell-death pathway.

The authors declare that they have no competing financial interests.

Present address: Department of Molecular Diagnostics, Genentech, 1 DNA Way, South San Francisco, CA 94080.

^|| Corresponding author. E-mail address: deveraux{at}gnf.org.

This article has been cited by other articles:

				B. Pyhtila, T. Zheng, P. J. Lager, J. D. Keene, M. C. Reedy, and C. V. Nicchitta Signal sequence- and translation-independent mRNA localization to the endoplasmic reticulum RNA, March 1, 2008; 14(3): 445 - 453. [Abstract] [Full Text] [PDF]

				D. Ovcharenko, K. Kelnar, C. Johnson, N. Leng, and D. Brown Genome-Scale MicroRNA and Small Interfering RNA Screens Identify Small RNA Modulators of TRAIL-Induced Apoptosis Pathway Cancer Res., November 15, 2007; 67(22): 10782 - 10788. [Abstract] [Full Text] [PDF]

				Y. Lustig, Y. Vagima, H. Goldshmidt, A. Erlanger, V. Ozeri, J. Vince, M. J. McConville, D. M. Dwyer, S. M. Landfear, and S. Michaeli Down-Regulation of the Trypanosomatid Signal Recognition Particle Affects the Biogenesis of Polytopic Membrane Proteins but Not of Signal Peptide-Containing Proteins Eukaryot. Cell, October 1, 2007; 6(10): 1865 - 1875. [Abstract] [Full Text] [PDF]

				H. Malhi, F. J Barreyro, H. Isomoto, S. F Bronk, and G. J Gores Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity Gut, August 1, 2007; 56(8): 1124 - 1131. [Abstract] [Full Text] [PDF]

				J. Cheng, B. L. Hylander, M. R. Baer, X. Chen, and E. A. Repasky Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol. Cancer Ther., July 1, 2006; 5(7): 1844 - 1853. [Abstract] [Full Text] [PDF]

				S. Rottmann, Y. Wang, M. Nasoff, Q. L. Deveraux, and K. C. Quon From the Cover: A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3{beta}/FBW7 loss of function PNAS, October 18, 2005; 102(42): 15195 - 15200. [Abstract] [Full Text] [PDF]

				Y. Lustig, H. Goldshmidt, S. Uliel, and S. Michaeli The Trypanosoma brucei signal recognition particle lacks the Alu-domain-binding proteins: purification and functional analysis of its binding proteins by RNAi J. Cell Sci., October 1, 2005; 118(19): 4551 - 4562. [Abstract] [Full Text] [PDF]

				D. OVCHARENKO, R. JARVIS, S. HUNICKE-SMITH, K. KELNAR, and D. BROWN High-throughput RNAi screening in vitro: From cell lines to primary cells RNA, June 1, 2005; 11(6): 985 - 993. [Abstract] [Full Text] [PDF]